89467-36-7

Basic information

• Product Name: (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one
• Synonyms: (2S)-2-methyl-1-[(1S)-1-phenylethyl]piperidin-4-one;4-Piperidinone, 2-methyl-1-[(1S)-1-phenylethyl]-, (2S)-;EOS-61955
• CAS NO: 89467-36-7
• Molecular Formula: C₁₄H₁₉NO
• Molecular Weight: 217.30676
• Mol File: 89467-36-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 319.1±22.0 °C(Predicted)
• Appearance: /
• Density: 1.036±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 7.21±0.40(Predicted)
• CAS DataBase Reference: (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one(89467-36-7)
• EPA Substance Registry System: (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one(89467-36-7)

Safety Data

• Hazardous Substances Data: 89467-36-7(Hazardous Substances Data)

Usage

General Description

(S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one is a chemical compound with the molecular formula C14H21NO. It is a ketone derivative with a piperidine ring and a phenylethyl substituent. (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one is used in organic chemistry as a chiral building block for the synthesis of various pharmaceuticals and biologically active compounds. It also exhibits potential pharmacological and therapeutic properties, making it a valuable compound for research and drug development. Additionally, (S)-2-Methyl-1-((S)-1-phenylethyl) piperidin-4-one has been studied for its potential use in the treatment of various medical conditions, including neurological and psychiatric disorders.

Upstream product

• 2627-86-3 (S)-1-phenyl-ethylamine 
• 1826-67-1 vinyl magnesium bromide 
• 109480-79-7 (E)-N-methoxy-N-methyl-2-butenamide 
• 10575-36-7 (1E,4E)-hexa-1,4-dien-3-one 
• 35172-85-1 1,4-hexadien-3-one 
• 27806-90-2 1,2-dimethyl-4-piperidone iodomethylate 
• 13604-71-2 1-butyl-2-methyl-4-piperidone 
• 2627-86-3 (-)-α-methylbenzylamine 
• 103539-59-9 1-butyl-2-methyl-4-piperidone methiodide 

Downstream Products

• 89467-37-8 (R)-2-methyl-1-((S)-1-phenylethyl)piperidin-4-one 
• 790667-49-1 (S)-2-methyl-4-oxopiperidine-1-carboxylic acid tert-butyl ester 
• 89451-58-1 (+)-cis-2-methyl-4-piperidol 
• 89451-56-9 (+)-cis-1-(S-α-phenylethyl)-2-methyl-4-piperidol 
• 89451-57-0 (-)-cis-1-(S-α-phenylethyl)-2-methyl-4-piperidol 

Relevant articles and documents

INHIBITOR OF BTK AND MUTANTS THEREOF

The disclosure includes compounds of Formula (I) (1) wherein Q0, Q1, Q2, Q3, Q4, Z, W, i, j, m, n, Warhead, R0, R1, R3, R4, R5, R6, and R7, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

PYRAZOLO PYRIMIDINE DERIVATIVES

The present invention relates to pyrazolo pyrimidine derivatives, to methods of preparing these, to combinations and pharmaceutical composition comprising these, and to their use in the treatment of diseases and disorders which may for example involve autoimmune diseases, angiogenesis, pain, and/or inflammatory diseases.

(PIPERIDINYLOXY)PHENYL, (PIPERIDINYLOXY)PYRIDINYL, (PIPERIDINYLSULFANYL)PHENYL AND (PIPERIDINYLSULFANYL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS

The present invention relates to compounds of formula 1: and pharmaceutically acceptable acid addition sails thereof. The compounds of the present invention are useful for activating 5-HTIF receptors, inhibiting neuronal protein extravasation, and for the treatment or preverition of migraine in mammals, particularly humans.